SPRINGWORKS THERAPEUTICS, INC.: cashflow_financing
| Value | {"amount": -552000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2024-01-01 – 2024-03-31 |
| Status | current |
| Entity | SPRINGWORKS THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:59:17.328140+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/8458d158-8042-4f35-876c-8ec7166787fe
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001773427-24-000018Retrieved: 2026-08-19T17:59:17.328140+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001773427/cashflow-financing/2024-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/8458d158-8042-4f35-876c-8ec7166787fe
History
- no predecessors — first report